P ropofol (2,6-diisopropylphenol) is a widely used intravenous anesthetic agent. In addition to its anesthetic effects, propofol has a protective effect against oxidative stress-mediated cell injuries (1) . Propofol inhibits reactive oxygen species (ROS) such as hydrogen peroxide (H 2 O 2 )-induced injury in cultured endothelial cells and cardiac cells in vitro (2, 3) and in hearts with ischemia/reperfusion injury in vivo (4) . However, propofolmediated antioxidative effect might be cell-specific. For example, in a recent study, propofol was found to facilitate the process of cell death induced by H 2 O 2 in rat thymocytes (5) .
ROS are reactive derivatives of O 2 metabolism, including superoxide anion (O 2 Ϫ ), H 2 O 2 , hydroxyl radical, and nitric oxide. All types of vascular cells produce ROS, primarily via cell membraneassociated NAD(P)H oxidase, uncoupled nitric oxide synthase, xanthine oxidase, and mitochondria. It is well-established that the increased ROS, such as H 2 O 2 , is a common pathologic component in many vascular diseases, including atherosclerosis, hypertension, restenosis after angioplasty or bypass, diabetic vascular complications, transplantation arteriopathy, and vascular aneurysm (6 -12) . The increased oxidative stress induced by ROS is related to vascular smooth muscle cell (VSMC) injury (apoptosis) and proliferation, which are critical cellular events in the pathogenesis of the aforementioned vascular diseases (13) (14) (15) . Currently, the biological effect of propofol on ROSmediated injury on VSMCs is unclear. Propofol is widely used in patients with diverse vascular diseases with increased ROS; uncovering the effect of propofol on VSMCs is therefore very important in clinical anesthesiology and critical care medicine.
MicroRNAs (miRNAs) have emerged as a novel class of endogenous, small, noncoding RNAs that negatively regulate ϳ30% of genes in a cell via degradation or translational inhibition of their target mRNAs (16 -19 (20) . However, the potential involvement of miR-21 in propofol-mediated effect on VSMCs is unknown.
The objectives of the current study were to determine the effect of propofol on H 2 O 2 -induced injury on VSMCs and vascular walls, and to elucidate the molecular mechanisms involved. Surprisingly, in contrast to its antioxidative effect on other cells, we found propofol exacerbated injury responses in VSMCs and in vascular walls with increased H 2 O 2 , at least in part, through miR-21 and its target gene, PDCD4. 
MATERIALS AND METHODS

Cell Culture
VSMCs were obtained from the aortic media of male Sprague-Dawley rats (specific pathogen free, 5 wks old) using an enzymatic dissociation method as described (20) . VSMCs were cultured with DMEM containing 10% fetal bovine serum. Cells between passage 3 and 6 were applied for the experiments. 
Cell Treatments
Assessment of Cell Viability and Cell Death
Cell survival was measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay as described in our previous study (21) . In brief, VSMCs were cultured in 96-well plate and 10 L of MTT (Sigma) were added to each well for 4 hrs. The product was then dissolved in isopropanol and quantified spectrophotometrically at a wave- length of 570 nM. Cell death was determined by trypan blue exclusion test. In this experiment, the VSMCs were detached by trypsinizing and were collected after centrifugation. The cells were resuspended in phosphatebuffered saline and incubated with equal volume of 0.4% trypan blue for 5-10 mins at room temperature. The number of dead cells (stained cells) were counted using a hemocytometer and expressed as a percentage of the total cells counted.
Evaluation of Cell Apoptosis
VSMC apoptosis was determined by terminal deoxynucleotide transferase dUTP nick end labeling (TUNEL) staining and the expression of the cleaved caspase-3 (the active form of caspase-3) (20 -22) . TUNEL staining was performed using the in situ cell death detection kit (Roche, Indianapolis, IN) according to the manufacturer's protocol. The number of TUNEL-positive cells was counted under a fluorescence microscope. The cleaved caspase-3 and intact caspase-3 were examined by Western blotting (see "Western Blot Analysis of Caspase-3 and PDCD4" below).
Oligo Transfection and miR-21 Up-Regulation in Cultured VSMCs
Oligo transfection was performed according to an established protocol (20 -22) . Briefly, cells were transfected using a transfection reagent (Qiagen, Valencia, CA) 24 hrs after seeding into the well. Transfection complexes were prepared according to the manufacturer's instructions. For the miR-21 up-regulation, premiR-21 (Ambion) was added directly to the complexes at a final oligonucleotide concentration of 30 nM. The transfection medium was replaced 4 hrs after transfection by the regular culture medium. Vehicle control and oligo control (Ambion) were applied.
Measurement of mir-21
The miR-21 levels were determined by quantitative real-time polymerase chain reaction as described (20 -22) . Briefly, RNAs from VSMCs were isolated with mirVana miRNA Isolation Kit (Ambion). Quantitative real-time polymerase chain reaction for miR-21 was performed on cDNA generated from 50 ng of total RNA using the protocol of the mirVana quantitative real-time polymerase chain reaction miRNA detection kit (Ambion). Amplification and detection of specific products were performed with a Lightcycler 480 Detection System (Roche). As an internal control, U6 was used for miR-21 template normalization. Fluorescent signals were normalized to an internal reference, and the threshold cycle (Ct) was set within the exponential phase of the polymerase chain reaction. The relative gene expression was calculated by comparing cycle times for each target polymerase chain reaction. The target polymerase chain reaction Ct values were normalized by subtracting the U6 Ct value, which provided the ⌬Ct value. The relative expression level between treatments was then calculated using the following equa- 
Western Blot Analysis of Caspase-3 and PDCD4
The expressions of cleaved caspase-3 and PDCD4 were determined by Western blot analysis as described (21) . The whole cell lysates were prepared in RIPA buffer (50 mM TrisḢ Cl, pH 8, 150 mM NaCl, 1% Nonidet P-40, 0.1% SDS, 1% Triton X-100 plus proteinase inhibitors; Sigma). Protein concentration was determined by Bradford assay, and samples containing 30 g were separated by 12% SDS-PAGE. Proteins were transferred to nitrocellulose membranes (Hybond ECL, Amersham Pharmacia Biotech). After membranes were blocked in 5% nonfat milk in 20 mM Tris⅐HCl, 150 mM NaCl, and 0.05% Tween 20 for 1 hr at room temperature, the membranes were incubated overnight at 4°C with different primary monoclonal antibodies: anti-cleaved caspase-3 (1:1000; Asp175; Cell Signaling Technology, Danvers, MA, #9664), anti-intact caspase-3 (8G10) (1:1000; Cell Signaling Technology, #9665), and anti-PDCD4 (1:1500; Santa Cruz Biotechnology, Santa Cruz, CA). GADPH antibody (1:5000 dilution; Cell Signaling Technology) was used as a loading control. The membranes were then incubated with secondary antibody conjugated to horseradish peroxide for 1 hr at room temperature and were exposed to enhanced chemiluminescence reagents. Densitometric analysis was performed to quantify the signal intensity.
Rat Carotid Artery Balloon Injury, Propofol Treatment, and Cell Apoptosis Assay in Vascular Walls in Vivo
Carotid artery balloon injury was induced in male Sprague-Dawley rats (specific pathogen-free, 250 -300 g) as described in our previous studies (22) (23) (24) . Briefly, rats were anesthetized with ketamine (80 mg/kg)/xylazine (5 mg/kg). Under a dissecting microscope, the right common carotid artery was exposed through a midline cervical incision. A 2-Fr Fogarty catheter (Baxter Edwards, Irvine, CA) was introduced via an arteriotomy in the external carotid artery, and then the catheter was advanced to the proximal edge of the omohyoid muscle. To produce carotid artery injury, we inflated the balloon with saline and withdrew it three times from just under the proximal edge of the omohyoid muscle to the carotid bifurcation. After injury, the external carotid artery was permanently ligated with a 6-0 silk suture, and blood flow in the common carotid artery was restored. Sham-opened animals without vessel injury were used as controls. At 4 days after angioplasty, the control
ment, the animals were euthanized and the carotid arteries were isolated for apoptosis assay. The dose we used in the rat study was based on previous reports (25, 26) . Detection of apoptotic cells in the vascular walls was performed using the TUNEL method by immunofluorescence (22) . Apoptotic cells were quantified by counting the percentage of TUNEL-positive cells against total nucleated cells in the tissue section. The average of the six sections was used as the parameter for one animal. The apoptosis of the vascular cells was further verified by cleaved caspase-3 via Western blot.
Statistics
All data are presented as mean Ϯ standard error. For relative cell viability or gene expression, the mean value of the control group was defined as 1 or 100%. If normality and homogeneity of variance had been proven (Shapiro Wilks test and Levene's test, respectively), then one-way analysis of variance followed by Scheffe test were used for statistical evaluation of the differences among three or more groups data; otherwise, Kruskal-Wallis one-way analysis of variance was used and Wilcoxon-MannWhitney test with a Bonferroni correction was used for multiple comparisons. Two-tailed unpaired Student's t test was used for statistical evaluation of the differences between two groups' data. All statistics were analyzed using SPSS 17.0 (SPSS, Chicago, IL) or SAS (SAS Institute Inc, Cary, NC) statistical analysis program. A value of p Ͻ .05 was considered statistically significant.
RESULTS
Propofol Promotes Cell Death and Reduces Cell Viability in VSMCs Pretreated With H 2 O 2
As shown in Figure 1 , propofol (10 -50 M) and its vehicle have no effect on VSMC viability after 24-hr treatment (Fig. 1A) . In contrast, incubation with H 2 O 2 resulted in decreased VSMC viability in a dose-dependent manner (Fig. 1B) . Notably, H 2 O 2 -induced decrease in cell viability was significantly exacerbated by propofol at clinically relevant concentrations (10 -50 M) as demonstrated by MTT assay (Fig. 1C) . Accordingly, H 2 O 2 -induced cell death was facilitated by propofol (Fig. 2) .
Propofol Exacerbates H 2 O 2 -Induced VSMC Apoptosis
Apoptosis is an important cellular mechanism in H 2 O 2 -induced cell injury. To determine the effect of propofol on VSMC apoptosis, TUNEL staining was performed. As shown in Figure 3 , propofol had no effect on apoptosis in VSMCs without H 2 O 2 treatment. However, in H 2 O 2 -pretreated VSMCs, H 2 O 2 -induced cell apoptosis was strongly increased by propofol at 6 hrs after treatment (Fig.  4A) . Representative TUNEL-stained photomicrographs of VSMCs treated with Figure 4B . The effect of propofol on H 2 O 2 -induced VSMC apoptosis was further confirmed by cleaved caspase-3 expression because the increased cleaved caspase-3 expression was found in H 2 O 2 -pretreated(200 M) VSMCs after treatment with propofol (Fig. 5) .
Involvement of miR-21 in Propofol-Mediated Pro-injury Effects on VSMCs
To test the potential involvement of miR-21 in propofol-mediated pro-injury effects on VSMCs, miR-21 levels in VSMCs treated with H 2 O 2 and propofol were determined. As shown in Figure  6A , miR-21 expression was increased by H 2 O 2 . Although propofol itself had no significant effect on miR-21 expression in VSMCs without H 2 O 2 treatment, H 2 O 2 -induced up-regulation of miR-21 was significantly attenuated by propofol (Fig. 6A) .
To further determine the biological function of miR-21 in propofol-mediated cellular effects, the expression of miR-21 was up-regulated by premiR-21 (Ambion) to overcome propofol-mediated downregulation of miR-21 in H 2 O 2 -treated cells. As shown in Figure 6B , miR-21 expression was successfully increased by premiR-21 (30 nM). Interestingly, propofol-mediated pro-injury effect on H 2 O 2 -pretreated VSMCs was significantly inhibited by the overexpression of miR-21 as demonstrated by the decreased VSMC apoptosis ( Fig. 6C and D) . In contrast, control oligo had no effect on VSMC apoptosis ( Fig. 6C and D) .
To further confirm the biological role of miR-21 in propofol-mediated cellular effect, the effect of propofol on the downstream molecule of miR-21, PDCD4, was determined in H 2 O 2 -treated cells. The expression of PDCD4 was increased by propofol, which matched the propofolmediated expression change of miR-21 (Fig. 6E) .
Propofol Exacerbates Cell Apoptosis in Rat Vascular Walls With Increased ROS
Increased ROS including H 2 O 2 is an important mechanism of VSMC apoptosis in balloon-injured vascular walls. To test the effect of propofol on VSMCs with increased H 2 O 2 in the vascular walls in vivo, balloon angioplasty was performed in rat carotid arteries. On day 4 after injury, the animals were treated with vehicle or propofol for 6 hrs. As expected, VSMC apoptosis was increased in ballooninjured vessels as demonstrated by TUNEL (Fig. 7A and B) and Western blot analysis of the cleaved caspase-3 ( Fig. 7C  and D) . Propofol had no effect on cell apoptosis in normal vessels. Interestingly, the cell apoptosis in the ballooninjured vascular walls was significantly increased after treatment with propofol. Representative TUNEL-stained photomicrographs of normal uninjured vessel sections and balloon-injured vessel sections treated with vehicle or propofol are shown in Figure 7A .
DISCUSSION
Oxidative injury of VSMCs induced by increased ROS such as H 2 O 2 in the vascular walls is an important mechanism in the development of many vascular diseases (6 -12) . Propofol, a widely used general anesthetic, is reported to have a protective effect on ROS-mediated injuries of cardiac cells and vascular endothelial cells via its antioxidant properties (2-4). We thus hypothesized that propofol might also have an antioxidative effect in VSMCs. Unexpectedly, although propofol has no injury effect on normal VSMCs and normal vessels, it significantly increased H 2 O 2 -induced injury responses in cultured VSMCs and in arteries after angioplasty. The pro-injury effect of propofol on VSMCs with increased H 2 O 2 is not limited in rat cells, because the similar effect was found in human aortic VSMCs pretreated with H 2 O 2 (Supplemental The unexpected results from the current study revealed that the antioxidative effect of propofol may be cell-and oxidative condition-specific. Indeed, we did not see any injury effects on VSMCs and vessels without oxidative stress. However, in VSMCs and vessels with increased ROS, a significant pro-injury was demonstrated after treatment with propofol. In contrast, no obvious injury was found in rat endothelial cells treated with H 2 O 2 and propofol (data not shown). One recent study also supports our opinion that the antioxidative effect of propofol is cellspecific. Chikutei et al (5) found that propofol promoted the process of cell death induced by H 2 O 2 in rat thymocytes. However, under the same experimental conditions, in contrast to that in thymocytes, they found propofol was able to protect rat brain neurons against the oxidative stress induced by H 2 O 2 , although the mechanism was not investigated (5) . In addition, propofol-mediated pro-injury effect on VSMCs was likely ROS-specific, because the effect was also found in VSMCs pretreated with exogenous superoxide (O 2 Ϫ ) (generated by a xanthine/ xanthine oxidase reaction [100 mol/L xanthine ϩ 10 mU/L xanthine oxidase]), but not in VSMCs pretreated with exogenous reactive nitrogen species, peroxynitrite (ONOO Ϫ ) (produced by sodium nitroprusside [1 mol/L SNP] and the xanthine/xanthine oxidase reaction; data not shown).
Clinically relevant concentrations of propofol for general anesthesia are ϳ10 -30 M as reported previously (27) (28) (29) (30) . In the current study, we identified that the pro-injury effect of propofol could occur at as low as 10 M (Figs. 1  and 2 ). Another important parameter in propofol-mediated pro-injury effect is the exposed time. In the current study we have found that exposure of propofol for 3 hrs was able to induce pro-injury effects on VSMCs. The effects of propofol at early time points should be determined in future studies. It should be noted that the exposure of propofol may be evanescent after a bolus administration because of its large volume of distribution and rapid clearance. However, propofol not only is used as an intravenous induction agent but also is commonly used as a more long-term infusion as part of a sedativeanalgesic protocol. Thus, the novel finding in this study will still have clinical significance in patients with long-term exposure of propofol, especially in patients with ischemia or reperfusion or both who receive concurrent and ongoing propofol.
The molecular mechanisms involved in propofol-mediated pro-injury effect are currently unclear. In the study of Chikutei et al (5) , these investigators thought that propofol might affect the cells with phosphatidylserine-exposed membranes, which could be induced by H 2 O 2 in thymocytes, resulting in cell death. It is well established that although the damage stimuli are diverse, the fate of a cell under any kind of damage conditions is decided by the gene changes inside the cell (31, 32) . Some of these responsive genes are pro-injury genes leading the cells to injury and death, whereas some of them are intrinsic defensive genes that protect the cells against damages (31, 32) . miRNAs are a novel class of endogenous, small, noncoding RNAs that negatively regulate gene expression (16 -19) . Our recent studies demonstrated that miR-21 is a critical anti-injury miRNA against Figure 7 . Propofol exacerbates cell apoptosis in rat vascular walls with increased reactive oxygen species. Balloon angioplasty was performed in rat carotid arteries to increase hydrogen peroxide (H 2 O 2 ) in vascular walls. Sham-opened group was used as the normal uninjured control. At 4 days after surgery, the animals were treated with vehicle or propofol (12 mg/kg Ϫ1 hr Ϫ1 ), intravenous) for 6 hrs and the apoptosis was determined in vessel sections by terminal deoxynucleotide transferase dUTP nick end labeling (TUNEL) staining and the expression of the cleaved caspase-3. A, Representative TUNELstained vessel sections from animals with different treatments. B, Quantitative analysis of TUNELstained apoptotic cells in vessels from animals with different treatments. C, Representative Western blots of the cleaved caspase-3 and intact caspase-3 in vessels from animals with different treatments. D, Quantitative analysis of the expression of cleaved caspase-3 and intact caspase-3 in vessels from animals with different treatments (n ϭ 8; *p Ͻ .05 compared with uninjured control; #p Ͻ .05 compared with balloon-injury treated with vehicle). GAPDH, glyceraldehyde 3-phosphate dehydrogenase.
cell death (apoptosis and necrosis) induced by ischemic and oxidative injuries (20, 21, 33 ). In the current study, we identified that miR-21 is involved in propofol-mediated pro-injury effect on VSMCs based on the following three observations. First, H 2 O 2 -induced miR-21 up-regulation was inhibited by propofol. Second, in H 2 O 2 -pretreated VSMCs, cell apoptosis induced by propofol was significantly reduced by restoration of miR-21 expression. Third, propofol was able to increase the expression of miR-21 target gene, PDCD4, in H 2 O 2 -treated VSMCs. However, up-regulation of miR-21 can only partially inhibit propofol-mediated injury on VSMCs, suggesting that other unidentified molecular mechanisms should be investigated in future studies. It should be noted that caspase-3 is not a direct target of miR-21. However, miR-21 may indirectly affect caspase-3 expression through its target gene, PDCD4.
CONCLUSIONS
The current study identifies, for the first time, that the widely used anesthetic propofol can exacerbate cell injury in VSMCs and in vascular walls with increased ROS, at least in part, through miR-21 and its target gene, PDCD4. Because an increase in ROS is a common pathologic component in many vascular diseases, the novel findings in this study suggest that propofol might have some application limitations in patients with vascular disease, although additional clinical evidence should be provided in future studies.
